Mobileye turns in 42% rise in quarterly net; Super-Sol boosts profits in quarter despite declining sales; Shares end lower, weighted down by Teva Pharmaceuticals, energy stocks.
Central bank cites rebound in economic growth and higher inflation in ruling out using unconventional monetary tools.
Extent of banks' losses on Eliezer Fishman comes as the ex-tycoon's lawyers level attack on special administrator appointed to oversee his family's personal assets.
Haifa Chemicals still faces court decision on fate of controversial facility that might close it down shortly.
Both companies are profitable, generate returns on equity of 10% to 15% a year, and would likely distribute dividends. This is the kind of thing that investors would happily welcome.
Israeli shares haven’t exactly boomed since Election Day, but they should have, since paranoia and defense spending are on the rise, and Lethal Toys R Us. So what’s an investor to do?
Riding consumer interest in healthier eating, the fizzy-drink device maker restored profitability and its share price.
While modest fashion bloggers catch eyes on Instagram, the need for clothes that will suit the Muslim fashionista is quickly being translated into demand.
The rise comes despite the cold and rainy weather, which would normally have resulted in a decline in sales of beverages and in retail sales in general.
Drone maker Aeronautics is on the way to billion-shekel IPO in Tel Aviv; Delek Group receives $1.75 billion loan for its share of Leviathan development costs.